WallStreetZenWallStreetZen

NYSEMKT: CPHI
China Pharma Holdings Revenue

OverviewEarningsRevenue
DividendOwnership
China Pharma Holdings revenue was $4.53M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.1M, up 3.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CPHI annual revenue was $4.5M, with -35.4% growth year-over-year.

CPHI past revenue growth

How has CPHI's revenue growth performed historically?

Company
-35.41%
Industry
10.38%
Market
20.68%
CPHI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CPHI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CPHI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CPHI revenue history

Current Revenue
$4.5M
Current Earnings
-$4.7M
Current Profit Margin
-104.6%

Be the first to know when CPHI announces revenue.

CPHI Revenue History By Year

CPHI Yearly RevenueCPHI RevenueCPHI ChangeCPHI Revenue Growth
2024-12-31$4.53M-$2.48M-35.41%
2023-12-31$7.01M-$1.09M-13.48%
2022-12-31$8.10M-$1.54M-15.95%
2021-12-31$9.64M-$1.22M-11.27%
2020-12-31$10.87M-$57.49k-0.53%
2019-12-31$10.92M-$1.41M-11.41%
2018-12-31$12.33M-$881.63k-6.67%
2017-12-31$13.21M-$2.36M-15.15%
2016-12-31$15.57M-$4.78M-23.49%
2015-12-31$20.35M-$1.78M-8.05%
2014-12-31$22.13M-$10.67M-32.53%
2013-12-31$32.81M-$21.70M-39.81%
2012-12-31$54.51M-$26.66M-32.85%
2011-12-31$81.17M$6.78M+9.11%
2010-12-31$74.39M$12.69M+20.57%
2009-12-31$61.70M$10.73M+21.05%
2008-12-31$50.97M$17.78M+53.58%
2007-12-31$33.19MN/AN/A

1 of 2

China Pharma Holdings Revenue FAQ

What was CPHI's revenue last quarter?

China Pharma Holdings (NYSEMKT: CPHI) reported Q4 2024 revenue of $1.13 million up 47.25% year over year. In the same quarter last year, China Pharma Holdings's revenue was $2.15 million.

What was China Pharma Holdings's revenue in 2024?

China Pharma Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $4.53 million, a 35.41% decrease year over year.

How much does China Pharma Holdings make in a day?

Based on China Pharma Holdings annual revenue for the past five years, CPHI makes an average of $22,001.48 per day.

What was China Pharma Holdings's annual revenue growth in the past year?

As of Q2 2025, China Pharma Holdings's revenue has grown -35.41% year over year. This is 45.78 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.38%. China Pharma Holdings's revenue in the past year totaled $4.53 million.

How much does China Pharma Holdings make in a year?

China Pharma Holdings's revenue by year for the past five years is:
  • China Pharma Holdings's revenue for the twelve months ending Dec 31, 2024 was $4.53 million, a 35.41% decrease year over year.
  • China Pharma Holdings's annual revenue for Dec 31, 2023 was $7.01 million, a 13.48% decrease from 2022.
  • China Pharma Holdings's annual revenue for 2022 was $8.10 million, a 15.95% decrease from 2021.
  • China Pharma Holdings's annual revenue for 2021 was $9.64 million, a 11.27% decrease from 2020.
  • China Pharma Holdings's annual revenue for 2020 was $10.87 million, a 0.53% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.